Latest Lenalidomide Stories
17 abstracts include data from: NORTH CHICAGO, Ill., May 11, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced 17 abstracts from studies of the company's oncology pipeline are being presented
Application Designed to Support Conversion of Accelerated to Full FDA Approval THOUSAND OAKS, Calif., March 30, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S.
NESS ZIONA, Israel, March 16, 2015 /PRNewswire/ -- - Recognition of the unmet medical need and high therapeutic potential of ImMucin in Multiple
WOONSOCKET, R.I., March 12, 2015 /PRNewswire/ -- MultiCell Immunotherapeutics, Inc. (MCIT), a majority owned subsidiary of MultiCell Technologies, Inc.
FDA approves new uses of lenalidomide and panobinostat WHITE PLAINS, N.Y., Feb. 26, 2015 /PRNewswire-USNewswire/ --Two recent approvals by the U.S.
THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Feb.
EAST SETAUKTET, N.Y., Feb. 25, 2015 /PRNewswire/ -- Lixte Biotechnology Holdings Inc.
TAMPA, Fla., Feb. 4, 2015 /PRNewswire/ -- Oxis International, Inc.
US Submission Designed to Support Conversion From Accelerated to Full FDA Approval and Expansion of Current Approved Indication THOUSAND OAKS, Calif.
Data From Pivotal Trial Published in the New England Journal of Medicine and Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition THOUSAND OAKS, Calif.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.